Mechanism of Action - Entresto
Sacubitril/valsartan, a first-in-class ARNI, delivers simultaneous inhibition of neprilysin and blockade of the AT1 receptor. Sacubitril/valsartan is a sodium salt complex comprising sacubitril (AHU377), a prodrug, which is further metabolized to the...
Twitter Linkedin Facebook Pinterest Google plusCosentyx zelf-injectie gids
Download Dutch version .field-name-field-np4-expiry-date {display:none;}Guide d'autoinjection du Cosentyx
Download French version .field-name-field-np4-expiry-date {display:none;}Indications - Entresto
ENTRESTO ® is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction. ENTRESTO is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic...
Twitter Linkedin Facebook Pinterest Google plusPatient Resources - Entresto
Together for Better In the fight against heart failure condition, we work our hardest every day to develop innovative and effective medication to sustain a better life, keeping the patient in mind. We are aware that the result of...
Twitter Linkedin Facebook Pinterest Google plusENTRESTO®: Medication Diary ( French)
This booklet has been developed to help patients to manage heart failure better monitored and managed. To receive by post, click on the "Add to card" button below .field-name-field-np4-expiry-date {display:none;}ENTRESTO®: Medication Diary ( Dutch)
This booklet has been developed to help patients to manage heart failure better monitored and managed. .field-name-field-np4-expiry-date {display:none;} To receive by post, click on the "Add to card" button belowIndications
Reimbursement / eHealth - Lucentis
